B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates
Authors:
- M. MariottiMMM. Mariotti
- M. ThauvinMTM. Thauvin
- 1 January 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8891) , 211-212
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Parvovirus B19 Infection in Human Immunodeficiency Virus Type 1-Infected Persons Failing or Intolerant to Zidovudine TherapyThe Journal of Infectious Diseases, 1993
- Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionJournal of Clinical Microbiology, 1993
- Towards a new predictor of AIDS progression through the quantisation of HIV‐1 DNA copies by PCR in HIV‐infected individualsBritish Journal of Haematology, 1992
- Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reactionBritish Journal of Haematology, 1992
- Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentratesAmerican Journal of Hematology, 1992
- Letter to the editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirusAmerican Journal of Hematology, 1992
- Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 1988
- Six cases of hereditary spherocytosis revealed by human parvovirus infectionBritish Journal of Haematology, 1986
- TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 1983